Tradewinds Capital Management, LLC - CRISPR THERAPEUTICS AG ownership

Back to all holdings Add to watchlist

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 397 filers reported holding CRISPR THERAPEUTICS AG in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Tradewinds Capital Management, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$32,227
+421.8%
710
+545.5%
0.01%
+450.0%
Q2 2023$6,176
+24.1%
1100.0%0.00%0.0%
Q1 2023$4,976
+6.4%
110
-4.3%
0.00%0.0%
Q4 2022$4,675
-41.6%
1150.0%0.00%
-33.3%
Q3 2022$8,000
+14.3%
115
+4.5%
0.00%0.0%
Q2 2022$7,0000.0%1100.0%0.00%
+200.0%
Q1 2022$7,000
-12.5%
1100.0%0.00%0.0%
Q4 2021$8,000
+14.3%
110
+83.3%
0.00%0.0%
Q3 2021$7,000
-30.0%
600.0%0.00%
-50.0%
Q2 2021$10,000
+42.9%
600.0%0.00%
+100.0%
Q1 2021$7,000
-22.2%
600.0%0.00%
-50.0%
Q4 2020$9,000
+80.0%
600.0%0.00%
+100.0%
Q3 2020$5,000
+25.0%
600.0%0.00%0.0%
Q2 2020$4,000
+33.3%
600.0%0.00%0.0%
Q1 2020$3,000
-40.0%
60
-20.0%
0.00%
-50.0%
Q4 2019$5,000
+66.7%
75
+15.4%
0.00%
+100.0%
Q2 2019$3,0000.0%65
-23.5%
0.00%0.0%
Q1 2019$3,000–85–0.00%–
 Download
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2022
NameSharesValueWeighting ↓
Gilfoyle Management LLC 150$6,37612.96%
Versant Venture Management, LLC 498,558$22,629,54812.03%
NEA Management Company, LLC 1,587,854$72,072,6935.57%
ARK Investment Management 7,163,118$325,133,9132.49%
Nikko Asset Management Americas, Inc. 3,465,470$157,263,0291.88%
Integral Health Asset Management, LLC 275,000$12,482,2501.73%
Merlin Capital, Inc 9,092$412,6861.54%
Del-Sette Capital Management, LLC 33,977$1,542,2161.52%
Green Alpha Advisors, LLC 34,880$1,583,2031.22%
Ikarian Capital, LLC 2,039$9,255,0211.11%
View complete list of CRISPR THERAPEUTICS AG shareholders